Please ensure Javascript is enabled for purposes of website accessibility

Why Tilray Stock Dropped 28% in September

By Demitri Kalogeropoulos – Oct 5, 2020 at 9:33AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors pushed shares lower during the wider market's swoon.

What happened

Tilray (TLRY) shareholders trailed a declining market in September as the stock fell 28% compared to the S&P 500's 3.9% drop, according to data provided by S&P Global Market Intelligence.

That decline added to slumping returns for the pot stock, which is down over 70% so far in 2020.

A distributor displays medicinal marjuana.

Image source: Getty Images.

So what

Tilray's only corporate news update last month was its release trumpeting positive results in a study testing the effectiveness of medicinal cannabis to treat nausea in chemotherapy patients.

While that was good news for the industry, investors chose to focus instead on more concrete challenges facing Tilray and the wider marijuana niche, including regulatory burdens and uncertain growth opportunities. It didn't help that the company last reported only modest sales gains and continuing net losses for the fiscal second quarter. Sales gains slowed to 10% through late June, compared to a 126% spike in the prior quarter.

Now what

Those weak operating metrics mean that Tilray stock will likely stay pressured as long as investors' attitudes toward the marijuana stock niche remain conservative. Tilray can change that bearish narrative over the next few quarters, but only by demonstrating it is on a path toward sustainable profitability.

Demitri Kalogeropoulos has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Stocks Mentioned

Tilray, Inc. Stock Quote
Tilray, Inc.
TLRY

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.